# NVO — replay s2 — bf16

## Metadata

ticker: NVO
arm: bf16
sample: 2
served_name: financial-lora
source_findings: eval/runs/raw/v924f-findings/NVO_local-model.md
context_sha256: 304806f6d11902ae06c08926634dc32540d49ce4e40a8511d799361e23fed190
agent_core_sha256: f45e278f9722d5c331843a77692b154904f72edd059e6a3da48976a7945db44e
sampling: {"temperature": 0.1, "max_tokens": 512, "top_p": 0.8, "top_k": 20, "repetition_penalty": 1.1, "min_p": 0.0}
endpoint: http://localhost:30880
generated_utc: 2026-09-30T04:48:58Z
financial_health_prompt_sha256: f201d4687e60049c3f2bd241285d27ec127a44651099e0a2e0f460aace20ad18
financial_health_seed: 1020200
financial_health_response_model: financial-lora
financial_health_finish_reason: stop
financial_health_completion_tokens: 129
risk_factors_prompt_sha256: 6a2ff349b3f339a6b025e705e5847033d43f9dbb614b8b6cf303c29b7606434e
risk_factors_seed: 1020201
risk_factors_response_model: financial-lora
risk_factors_finish_reason: stop
risk_factors_completion_tokens: 83

## Stock data

{
  "ticker": "NVO",
  "company_name": "Novo Nordisk A/S",
  "current_price": 38.17,
  "currency": "USD",
  "market_cap": 168588673024.0,
  "pe_ratio": 9.566416,
  "forward_pe": 11.293336,
  "week_52_high": 64.16,
  "week_52_low": 35.12,
  "revenue": 329430990848.0,
  "net_income": 116442996736.0,
  "profit_margin": 0.35347,
  "dividend_yield": 4.56,
  "sector": "Healthcare",
  "industry": "Drug Manufacturers - General"
}

<!-- replay-section: Financial Health -->
### Financial Health
Novo Nordisk A/S trades at $38.17 per share in the healthcare sector. The company carries a market capitalization of $16.8 trillion and a P/E ratio of 9.5x (11.3x forward), a premium valuation compared to its peers. Novo Nordisk reports net income of $11.6 billion annually, a net profit margin of 35.3%. The company also pays out a dividend yield of 4.56%, which represents an annualized return of 4.56% on an investor's initial investment.

<!-- replay-section: Risk Factors -->
### Risk Factors

- The company faces intense competition in its industry.
- The company may face regulatory challenges or changes in regulations affecting the company's business operations and financial performance.
- The company may experience significant fluctuations in its stock price due to factors such as market conditions, economic trends, competitive pressures, product development cycles, regulatory requirements, litigation matters, acquisitions and dispositions, and other factors beyond our control.
